Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Akash Tewari is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/16/2024 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 16.67% | Akash Tewari45% | $63 → $70 | Upgrade | Hold → Buy | Get Alert |
| 11/15/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 33.2% | Akash Tewari45% | → $95 | Initiates | → Outperform | Get Alert |
| 09/17/2024 | BNTX | Buy Now | BioNTech | $99.01 | 51.5% | Akash Tewari45% | $96 → $150 | Upgrade | Hold → Buy | Get Alert |
| 09/13/2024 | BNTX | Buy Now | BioNTech | $99.01 | -3.04% | Akash Tewari45% | $90 → $96 | Maintains | Hold | Get Alert |
| 09/10/2024 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 377.61% | Akash Tewari45% | $10.6 → $16 | Upgrade | Hold → Buy | Get Alert |
| 08/28/2024 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -15% | Akash Tewari45% | $49 → $51 | Maintains | Hold | Get Alert |
| 08/19/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.71 | 72.27% | Akash Tewari45% | $177 → $189 | Maintains | Buy | Get Alert |
| 07/31/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 219.36% | Akash Tewari45% | $80 → $80 | Maintains | Buy | Get Alert |
| 07/16/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $33.34 | 124.96% | Akash Tewari45% | $29 → $75 | Upgrade | Underperform → Buy | Get Alert |
| 06/24/2024 | LLY | Buy Now | Eli Lilly and Co | $839.90 | 20.85% | Akash Tewari45% | $994 → $1015 | Maintains | Buy | Get Alert |
| 06/07/2024 | LLY | Buy Now | Eli Lilly and Co | $839.90 | 13.94% | Akash Tewari45% | $925 → $957 | Maintains | Buy | Get Alert |
| 04/09/2024 | ALKS | Buy Now | Alkermes | $33.03 | 51.38% | Akash Tewari45% | $42 → $50 | Maintains | Buy | Get Alert |
| 03/06/2024 | APGE | Buy Now | Apogee Therapeutics | $40.44 | 85.46% | Akash Tewari45% | $37 → $75 | Maintains | Buy | Get Alert |
| 03/05/2024 | APGE | Buy Now | Apogee Therapeutics | $40.44 | 134.92% | Akash Tewari45% | $46 → $95 | Maintains | Buy | Get Alert |
| 02/05/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 219.36% | Akash Tewari45% | $68 → $80 | Upgrade | Hold → Buy | Get Alert |
| 12/11/2023 | SYRE | Buy Now | Spyre Therapeutics | $18.40 | 68.48% | Akash Tewari45% | → $31 | Initiates | → Buy | Get Alert |
| 12/06/2023 | ARVN | Buy Now | Arvinas | $8.71 | 359.24% | Akash Tewari45% | $32 → $40 | Upgrade | Hold → Buy | Get Alert |
| 11/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $672.36 | 39.36% | Akash Tewari45% | $935 → $937 | Maintains | Buy | Get Alert |
| 11/28/2023 | SLRN | Buy Now | Acelyrin | $2.79 | 330.11% | Akash Tewari45% | $15 → $12 | Maintains | Buy | Get Alert |
| 10/16/2023 | PFE | Buy Now | Pfizer | $26.22 | 48.74% | Akash Tewari45% | $38 → $39 | Upgrade | Hold → Buy | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $839.90 | -26.78% | Akash Tewari45% | → $615 | Upgrade | Hold → Buy | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $40.44 | -15.92% | Akash Tewari45% | → $34 | Initiates | → Buy | Get Alert |
| 08/08/2023 | ENTA | Buy Now | Enanta Pharma | $6.44 | 179.5% | Akash Tewari45% | $49 → $18 | Downgrade | Buy → Hold | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $40.44 | -28.29% | Akash Tewari45% | → $29 | Initiates | → Buy | Get Alert |
| 07/21/2023 | LLY | Buy Now | Eli Lilly | $839.90 | -48.8% | Akash Tewari45% | $408 → $430 | Maintains | Hold | Get Alert |
| 07/17/2023 | ARGX | Buy Now | argenx | $619.97 | -17.25% | Akash Tewari45% | $497 → $513 | Maintains | Buy | Get Alert |
| 06/07/2023 | TERN | Buy Now | Terns Pharma | $3.16 | 469.62% | Akash Tewari45% | → $18 | Initiates | → Buy | Get Alert |
| 05/30/2023 | SLRN | Buy Now | Acelyrin | $2.79 | 1011.11% | Akash Tewari45% | → $31 | Initiates | → Buy | Get Alert |
| 04/20/2023 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 273.13% | Akash Tewari45% | $16 → $12.5 | Upgrade | Underperform → Hold | Get Alert |
| 04/03/2023 | LLY | Buy Now | Eli Lilly | $839.90 | -63.09% | Akash Tewari45% | $290 → $310 | Maintains | Hold | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $672.36 | 37.58% | Akash Tewari45% | $675 → $925 | Upgrade | Hold → Buy | Get Alert |
| 03/06/2023 | MRK | Buy Now | Merck & Co | $94.03 | 32.94% | Akash Tewari45% | → $125 | Initiates | → Buy | Get Alert |
| 03/06/2023 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 3.33% | Akash Tewari45% | → $62 | Initiates | → Hold | Get Alert |
| 03/06/2023 | LLY | Buy Now | Eli Lilly | $839.90 | -65.47% | Akash Tewari45% | → $290 | Initiates | → Hold | Get Alert |
| 03/06/2023 | PFE | Buy Now | Pfizer | $26.22 | 64% | Akash Tewari45% | → $43 | Initiates | → Hold | Get Alert |
| 12/20/2022 | ZYME | Buy Now | Zymeworks BC | $12.79 | -14% | Akash Tewari45% | $7.7 → $11 | Upgrade | Hold → Buy | Get Alert |
| 12/16/2022 | THRD | Buy Now | Third Harmonic Bio | $3.53 | 1.98% | Akash Tewari45% | $30 → $3.6 | Downgrade | Buy → Hold | Get Alert |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $5.46 | 211.36% | Akash Tewari45% | → $17 | Initiates | → Buy | Get Alert |
| 11/29/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 68.26% | Akash Tewari45% | $100 → $120 | Maintains | Buy | Get Alert |
| 11/11/2022 | EQRX | Buy Now | EQRx | — | — | Akash Tewari45% | $5.6 → $3.2 | Downgrade | Buy → Hold | Get Alert |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $3.53 | 749.86% | Akash Tewari45% | → $30 | Initiates | → Buy | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $672.36 | 0.39% | Akash Tewari45% | $536 → $675 | Upgrade | Underperform → Hold | Get Alert |
| 08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Akash Tewari45% | $68 → $68.5 | Downgrade | Buy → Hold | Get Alert |
| 06/21/2022 | ARVN | Buy Now | Arvinas | $8.71 | 382.2% | Akash Tewari45% | → $42 | Initiates | → Hold | Get Alert |
| 06/06/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.71 | 2.09% | Akash Tewari45% | → $112 | Assumes | → Buy | Get Alert |
| 06/06/2022 | RLAY | Buy Now | Relay Therapeutics | $3.35 | 288.06% | Akash Tewari45% | → $13 | Initiates | → Underperform | Get Alert |
| 06/06/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $672.36 | -20.28% | Akash Tewari45% | → $536 | Initiates | → Underperform | Get Alert |
| 03/18/2022 | EQRX | Buy Now | EQRx | — | — | Akash Tewari45% | → $5.6 | Initiates | → Buy | Get Alert |
| 10/07/2021 | ALKS | Buy Now | Alkermes | $33.03 | 8.99% | Akash Tewari45% | → $36 | Upgrade | Hold → Buy | Get Alert |
| 10/07/2021 | ENTA | Buy Now | Enanta Pharma | $6.44 | 1375.16% | Akash Tewari45% | → $95 | Initiates | → Buy | Get Alert |
| 10/07/2021 | CYTK | Buy Now | Cytokinetics | $43.45 | 72.61% | Akash Tewari45% | → $75 | Initiates | → Buy | Get Alert |
| 10/07/2021 | MDGL | Buy Now | Madrigal Pharmaceuticals | $340.77 | -55.69% | Akash Tewari45% | → $151 | Initiates | → Buy | Get Alert |
| 10/07/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Akash Tewari45% | → $68 | Initiates | → Buy | Get Alert |
| 10/07/2021 | EXEL | Buy Now | Exelixis | $37.05 | -24.43% | Akash Tewari45% | → $28 | Initiates | → Buy | Get Alert |
| 10/07/2021 | ARGX | Buy Now | argenx | $619.97 | -41.61% | Akash Tewari45% | → $362 | Initiates | → Buy | Get Alert |
| 10/07/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Akash Tewari45% | → $180 | Initiates | → Hold | Get Alert |
| 10/07/2021 | BNTX | Buy Now | BioNTech | $99.01 | 132.3% | Akash Tewari45% | → $230 | Initiates | → Hold | Get Alert |
| 03/12/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Akash Tewari45% | → $200 | Initiates | → Outperform | Get Alert |
| 03/12/2021 | CYTK | Buy Now | Cytokinetics | $43.45 | 15.07% | Akash Tewari45% | → $50 | Initiates | → Outperform | Get Alert |
| 03/12/2021 | EXEL | Buy Now | Exelixis | $37.05 | -5.53% | Akash Tewari45% | → $35 | Initiates | → Outperform | Get Alert |
| 03/12/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Akash Tewari45% | → $67 | Initiates | → Outperform | Get Alert |
| 03/12/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | Akash Tewari45% | → $107 | Initiates | → Outperform | Get Alert |
| 02/22/2018 | ALKS | Buy Now | Alkermes | $33.03 | — | Akash Tewari45% | — | Downgrade | Buy → Hold | Get Alert |
| 07/29/2016 | ALKS | Buy Now | Alkermes | $33.03 | 87.71% | Akash Tewari45% | $54 → $62 | Maintains | Buy | Get Alert |
| 03/10/2015 | ALKS | Buy Now | Alkermes | $33.03 | 136.15% | Akash Tewari45% | $80 → $78 | Maintains | Buy | Get Alert |
| 05/02/2014 | EXEL | Buy Now | Exelixis | $37.05 | -89.2% | Akash Tewari45% | $6 → $4 | Maintains | Hold | Get Alert |
| 01/31/2013 | ALKS | Buy Now | Alkermes | $33.03 | -15.23% | Akash Tewari45% | $22 → $28 | Maintains | Buy | Get Alert |
